The Williamson research group focuses on the development and evaluation of new diagnostic tests, and the translation of genomic technologies to infectious diseases. Their research has directly influenced the way microbiology is applied to clinical practice and public health, including responses to antimicrobial resistance, sexually-transmitted pathogens and COVID-19.
